Company · CIK 793171
Vitro Biopharma, Inc.
| CIK | 793171 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | NV |
| Business address | CO |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2001-09-14 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-267366 | 2022-09-09 | 2024-09-11 | 14 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-09-11 | EFFECTDeclared effective | 333-267366 | 9999999995-24-002788 |
| 2024-09-05 | S-1/AAmendment | 333-267366 | 0001493152-24-035112 |
| 2024-08-23 | S-1/AAmendment | 333-267366 | 0001493152-24-033726 |
| 2024-08-08 | S-1/AAmendment | 333-267366 | 0001493152-24-030726 |
| 2024-07-01 | S-1/AAmendment | 333-267366 | 0001493152-24-025754 |
| 2024-02-02 | S-1/AAmendment | 333-267366 | 0001493152-24-004779 |
| 2023-12-12 | S-1/AAmendment | 333-267366 | 0001493152-23-044572 |
| 2023-08-29 | S-1/AAmendment | 333-267366 | 0001493152-23-030408 |
| 2023-07-17 | S-1/AAmendment | 333-267366 | 0001493152-23-024669 |
| 2023-06-29 | S-1/AAmendment | 333-267366 | 0001493152-23-022972 |
| 2023-06-02 | S-1/AAmendment | 333-267366 | 0001493152-23-020018 |
| 2023-05-08 | S-1/AAmendment | 333-267366 | 0001493152-23-015832 |
| 2022-11-03 | S-1/AAmendment | 333-267366 | 0001493152-22-030380 |
| 2022-09-09 | S-1Registration filed | 333-267366 | 0001493152-22-025515 |